MELATONIN Mepha cpr ret 2 mg 21 pce
7680686810013
CH-68681
N05CH01
01.03.1.
1 / 3
google
Details
- Product number
- 6868101
- CPT
- -
- Packaging group
- 21
- Unit
- Tablette(n)
- Composition
- melatoninum 2 mg, ammonio methacrylatis copolymerum B, calcii hydrogenophosphas dihydricus, talcum, lactosum monohydricum 80 mg, magnesii stearas, silica colloidalis anhydrica, pro compresso obducto.
Articles (1)
Melatonin-Mepha 2 mg, Retardtabletten
Tabletten
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
80.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68681
- Drug name
- Melatonin-Mepha, Retardtabletten
- Galenic form
- RETT
- ATC Code
- N05CH01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 11/08/2022
- Authorization expiration date
- 10/08/2027
- IT number
- 01.03.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MELATONIN Mepha cpr ret 2 mg 21 pce
- Description (DE)
- MELATONIN Mepha Ret Tabl 2 mg 21 Stk
- Market launch
- 11/08/2022
- Narcotic (BTM)
- No